Cargando…

UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer

The UK Lung Screen (UKLS) is a randomised controlled trial of the use of low-dose multidetector CT for lung cancer screening. It completed the Health Technology Appraisal (HTA)-funded feasibility stage in October 2009 and the pilot UKLS will be initiated in early 2011. The pilot will randomise 4000...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baldwin, D R, Duffy, S W, Wald, N J, Page, R, Hansell, D M, Field, J K
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Group 2011
Materias:	Lung Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063456/ https://www.ncbi.nlm.nih.gov/pubmed/21317179 http://dx.doi.org/10.1136/thx.2010.152066

Ejemplares similares

Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial
por: Brain, Kate, et al.
Publicado: (2016)

UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening
por: Field, J K, et al.
Publicado: (2016)

Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial
por: Brain, Kate, et al.
Publicado: (2017)

Psychological outcomes of low-dose CT lung cancer screening in a multisite demonstration screening pilot: the Lung Screen Uptake Trial (LSUT)
por: Kummer, Sonja, et al.
Publicado: (2020)

Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial
por: Ali, Noor, et al.
Publicado: (2015)

The impact of trained radiographers as concurrent readers on performance and reading time of experienced radiologists in the UK Lung Cancer Screening (UKLS) trial
por: Nair, Arjun, et al.
Publicado: (2017)

Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis
por: Field, John K., et al.
Publicado: (2021)

Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening
por: Kim, Yeon Wook, et al.
Publicado: (2021)

CT screening for lung cancer
por: Diederich, Stefan
Publicado: (2008)

Evaluation of cardiovascular risk in a lung cancer screening cohort
por: Ruparel, Mamta, et al.
Publicado: (2019)

NEEDLE IN A HAYSTACK: OPPORTUNISTIC SCREENING OF LUNG NODULES AMIDST COVID-19 USING DEEP LEARNING
por: CHALLA, VIKASH, et al.
Publicado: (2022)

Defining the information needs of lung cancer screening participants: a qualitative study
por: Ruparel, Mamta, et al.
Publicado: (2019)

LDCT lung cancer screening in populations at different risk for lung cancer
por: Teles, Gustavo Borges da Silva, et al.
Publicado: (2020)

Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohort
por: Tisi, Sophie, et al.
Publicado: (2023)

Should sublobar resection be offered for screening-detected lung nodules?
por: Sihoe, Alan D. L.
Publicado: (2021)

NELSON lung cancer screening study
por: Zhao, Ying Ru, et al.
Publicado: (2011)

Artificial intelligence for detection and characterization of pulmonary nodules in lung cancer CT screening: ready for practice?
por: Schreuder, Anton, et al.
Publicado: (2021)

Lung cancer screening: rationale and background
por: Diederich, S.
Publicado: (2011)

Differential eligibility of African American and European American lung cancer cases using LDCT screening guidelines
por: Ryan, Bríd M
Publicado: (2016)

Analysis of lung cancer risk model (PLCO(M2012) and LLP(v2)) performance in a community-based lung cancer screening programme
por: Lebrett, Mikey B, et al.
Publicado: (2020)

What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?
por: O'Dowd, Emma L, et al.
Publicado: (2015)

‘Reduced’ HUNT model outperforms NLST and NELSON study criteria in predicting lung cancer in the Danish screening trial
por: Røe, Oluf Dimitri, et al.
Publicado: (2019)

Initial results of the National Lung Cancer Screening Trial
por: McLoud, T.C.
Publicado: (2011)

Survival of patients with small cell lung cancer undergoing lung resection in England, 1998–2009
por: Lüchtenborg, Margreet, et al.
Publicado: (2014)

Lung cancer screening: the preface
por: Snoeckx, Annemiek, et al.
Publicado: (2021)

Participation in lung cancer screening
por: Baldwin, David R., et al.
Publicado: (2021)

Genetically raised serum bilirubin levels and lung cancer: a cohort study and Mendelian randomisation using UK Biobank
por: Horsfall, Laura Jane, et al.
Publicado: (2020)

The person behind the nodule: a narrative review of the psychological impact of lung cancer screening
por: Quaife, Samantha L., et al.
Publicado: (2021)

Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial
por: Silvestri, Gerard A., et al.
Publicado: (2018)

Impact of radiographer immediate reporting of X-rays of the chest from general practice on the lung cancer pathway (radioX): a randomised controlled trial
por: Woznitza, Nick, et al.
Publicado: (2023)

Cone beam CT-guided navigation bronchoscopy: a cost-effective alternative to CT-guided transthoracic biopsy for diagnosis of peripheral pulmonary nodules
por: Kops, Stephan E P, et al.
Publicado: (2022)

Pulmonary nodule radiological diagnostic algorithm in lung cancer screening
por: Dziadziuszko, Katarzyna, et al.
Publicado: (2021)

Inflammatory status and lung function predict mortality in lung cancer screening participants
por: Pastorino, Ugo, et al.
Publicado: (2018)

Editorial on implementation of CT-based screening of lung cancer
por: Rzyman, Witold
Publicado: (2021)

Screen-detected solid nodules: from detection of nodule to structured reporting
por: Silva, Mario, et al.
Publicado: (2021)

Optimal resection rate for lung cancer in the UK: how high should we go?
por: Belcher, Elizabeth, et al.
Publicado: (2021)

Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients
por: Møller, Henrik, et al.
Publicado: (2018)

The radiologist’s role in lung cancer screening
por: Snoeckx, Annemiek, et al.
Publicado: (2021)

The Chest Australia Trial: a randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancer
por: Emery, Jon D, et al.
Publicado: (2019)

Managing screening-detected subsolid nodules—the Asian perspective
por: Sato, Masaaki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vrhdtf7rdgoisf7o079hf32v71